Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

被引：1
|
作者：
Qin, Hong [1 ]
You, Changqiao [1 ]
Yan, Feng [1 ]
Tan, Kefang [1 ]
Xu, Changgen [1 ]
Zhao, Rui [2 ]
Ekpo, Marlene Davis [2 ]
Tan, Songwen [2 ]
机构：
[1] NanHua Biomed CO Ltd, Res & Dev Dept, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
natural killer (NK) cells; immunosenescence; immunotherapy; cancer; chemotherapy; biotherapeutics; CAR-NK CELLS; CORD BLOOD; ADOPTIVE TRANSFER; CYTOKINE RELEASE; IN-VIVO; IMMUNOTHERAPY; ACTIVATION; EXPANSION; THERAPY; TRANSPLANTATION;
D O I：
10.3389/fonc.2022.1062765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Natural killer cell memory: challenges and opportunities for cancer immunotherapy
    Qu, Yuhua
    Zeng, Anhui
    Cheng, Yulu
    Li, Shengchun
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [2] Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion
    Lee, Da Yeon
    Kim, Yeongrin
    Park, Jin Song
    Choi, Ji U.
    Jeong, Hye Gwang
    Park, Chi Hoon
    ANTICANCER RESEARCH, 2023, 43 (09) : 3897 - 3904
  • [3] Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges
    Kong, Jun Chang
    Sa'ad, Mohammad Auwal
    Vijayan, Hema Manusri
    Ravichandran, Manickam
    Balakrishnan, Venugopal
    Tham, Seng Kong
    Tye, Gee Jun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [4] Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance
    Razmara, Aryana M.
    Judge, Sean J.
    Gingrich, Alicia A.
    Cruz, Sylvia M.
    Culp, William T. N.
    Kent, Michael S.
    Rebhun, Robert B.
    Canter, Robert J.
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [5] Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
    Nayyar, Gaurav
    Chu, Yaya
    Cairo, Mitchell S.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [6] Natural killer cell-based immunotherapy for lung cancer: Challenges and perspectives
    Zeng, Yongqin
    Lv, Xiuzhi
    Du, Juan
    ONCOLOGY REPORTS, 2021, 46 (05)
  • [7] Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics
    Kim, Kwang-Soo
    Han, Jun-Hyeok
    Park, Jung-Hoon
    Kim, Hyung-Keun
    Choi, Seung Hee
    Kim, Gyeong Ryeong
    Song, Haengseok
    An, Hee Jung
    Han, Dong Keun
    Park, Wooram
    Park, Kyung-Soon
    BIOMATERIALS, 2019, 221
  • [8] Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
    Philippa R. Kennedy
    Martin Felices
    Jeffrey S. Miller
    Stem Cell Research & Therapy, 13
  • [9] Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
    Kennedy, Philippa R.
    Felices, Martin
    Miller, Jeffrey S.
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [10] Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities
    Bisht, Kamlesh
    Merino, Aimee
    Igarashi, Rob
    Gauthier, Laurent
    Chiron, Marielle
    Desjonqueres, Alexandre
    Smith, Eric
    Briercheck, Edward
    Romee, Rizwan
    Alici, Evren
    Vivier, Eric
    O'Dwyer, Michael
    van de Velde, Helgi
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
12345